Dendritic cell-based vaccination in metastatic melanoma patients: phase II clinical trial
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2012-08-07 / Oncol. Rep. 2012 Oct;28(4):1131-8Dendritic cell engineering for tumor immunotherapy: from biology to clinical translation
/in Dendritic Cells, International Publications /von 2012-07-01 / Immunotherapy 2012 Jul;4(7):703-18Immunotherapies for non-small-cell lung cancer and mesothelioma
/in Dendritic Cells, International Publications, Malignant Pleural Mesothelioma /von 2012-06-28 / Lancet Oncol. 2012 Jul;13(7):e301-10Phase I immunotherapy trial using glioblastoma apoptotic body-pulsed dendritic cells.
/in Dendritic Cells, Glioblastoma, International Publications /von 2012-06-04 / J Clin Oncol 30, 2012 (suppl; abstr 2546)Autologous dendritic cell vaccine (ADCV) in combination with plasmapheresis (PP) and cyclophosphamide (Cy) in patients with disseminated melanoma: A phase II study.
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2012-06-04 / J Clin Oncol 30, 2012 (suppl; abstr e13059)WT1-targeted dendritic cell vaccination as a postremission treatment to prevent or delay relapse in acute myeloid leukemia.
/in Acute Leukemia, Dendritic Cells, International Publications /von 2012-06-04 / J Clin Oncol 30, 2012 (suppl; abstr 2506)The final report of a phase I trial of surgical resection with biodegradable carmustine (BCNU) wafer placement followed by vaccination with dendritic cells pulsed with tumor lysate for patients with glioblastoma.
/in Dendritic Cells, Glioblastoma, International Publications /von 2012-06-02 / J Clin Oncol 30, 2012 (suppl; abstr 2084)Correlation of survival with tumor antigen expression in patients with newly diagnosed glioblastoma receiving a multi-epitope pulsed dendritic cell vaccine.
/in Dendritic Cells, Glioblastoma, International Publications /von 2012-06-02 / J Clin Oncol 30, 2012 (suppl; abstr 2087)CD40 ligand/interferon-γ matured DC immunization with gp100 antigen HLA class I A *0201 restricted peptides in patients with newly diagnosed metastatic melanoma.
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2012-06-02 / J Clin Oncol 30, 2012 (suppl; abstr 2525)IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de